Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein. Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations. Archives of Rheumatology [Internet]. 2023 Jun. 30 [cited 2025 Oct. 3];38(2):249-56. Available from: http://anadolupsikiyatri.net/index.php/pub/article/view/1337